课题基金 / 基金详情

Impaired ability of aged human dendritic cells to maintain mucosal tolerance

Impaired ability of aged human dendritic cells to maintain mucosal tolerance
衰老的人类树突状细胞维持粘膜耐受性的能力受损
批准号:
8927521
负责人:
Anshu Agrawal
金额:
$30.72万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2019-04-30

项目摘要

项目成果

Anshu Agrawal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The risk of respiratory diseases increases significantly with advancing age. Elderly people are more prone to lung infections such as influenza and pneumonia and chronic illnesses such as asthma and obstructive pulmonary disease. The underlying mechanisms are not well understood. Airways are continuously being exposed to a wide variety of inhaled antigens majority of which are harmless. Dendritic cells (DCs) are key innate immune cells which are critical for initiation and generation of an effective immune response against invading pathogens as well as for maintaining tolerance against harmless inhaled antigens. Vitamin A metabolite, Retinoic acid (RA) plays a major role in inducing tolerance in respiratory DCs. Our preliminary data suggests that DCs from aged subjects are impaired in their response to retinoic acid resulting in loss of tolerance. Furthermore, aged DCs also affect the functions of airway epithelial cells to induce the secretion of various chemokines such as CXCL-10, CCL-26, and CCL-20 which can attract other cells into the airways and enhance inflammation. Therefore, we hypothesize that DCs from aged are impaired in their capacity to maintain tolerance at the respiratory surfaces which results in chronic inflammation and remodeling of the airways and increases the susceptibility of the elderly to respiratory illnesses. Our specific aims for the proposal are -1) to investigate the mechanisms responsible for impaired response of DCs from elderly to RA; 2) to determine the functional consequences of reduced RA metabolism in aged DCs; 3) to investigate the effect of altered RA response of aged DC on DC-epithelial cell crosstalk. Aged population is increasing worldwide and a better understanding of the mechanisms underlying the increased susceptibility of the elderly to respiratory diseases is required for design of novel and more effective treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
  • 批准号:
    10696138
  • 项目类别:
  • 资助金额:
    $37.37万
  • 财政年份:
    2022
  • 负责人:
    Anshu Agrawal
  • 依托单位:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
  • 批准号:
    10358338
  • 项目类别:
  • 资助金额:
    $37.06万
  • 财政年份:
    2021
  • 负责人:
    Anshu Agrawal
  • 依托单位:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
  • 批准号:
    10538647
  • 项目类别:
  • 资助金额:
    $35.17万
  • 财政年份:
    2021
  • 负责人:
    Anshu Agrawal
  • 依托单位:
Impaired ability of aged human dendritic cells to maintain mucosal tolerance
  • 批准号:
    8694995
  • 项目类别:
  • 资助金额:
    $31.67万
  • 财政年份:
    2014
  • 负责人:
    Anshu Agrawal
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: